Parallel Advisors »

4d Molecular Therapeutics In shares owned by Parallel Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $214k 20k 10.81
2024-06-30 $415k 20k 20.99
2024-03-31 $1.1k 33 31.85
2023-12-31 $668 33 20.27
2023-09-30 $0 0 0.00

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Amazon.com Stock (AMZN)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Vanguard Total Stk Mkt Etf (VTI)
Costco Wholesale Corp Stock (COST)

View all positions for Parallel Advisors

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
VR Adviser
Deep Track Capital
Goldman Sachs Group
Henderson Group
Vanguard Group
State Street Corporation
Novo A/S
Redmile Group
Braidwell
Casdin Capital
Geode Capital Management
Polar Capital Holdings

View all funds holding 4d Molecular Therapeutics In